Vijay Gorantla to Immunosuppressive Agents
This is a "connection" page, showing publications Vijay Gorantla has written about Immunosuppressive Agents.
Connection Strength
1.663
-
Honeyman C, Stark HL, Fries CA, Gorantla VS, Davis MR, Giele H. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review. J Plast Reconstr Aesthet Surg. 2021 02; 74(2):316-326.
Score: 0.160
-
Gorantla VS, Barker JH, Jones JW, Prabhune K, Maldonado C, Granger DK. Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies. Microsurgery. 2000; 20(8):420-9.
Score: 0.153
-
Wang H, Sobral MC, Snyder T, Brudno Y, Gorantla VS, Mooney DJ. Clickable, acid labile immunosuppressive prodrugs for in vivo targeting. Biomater Sci. 2020 Jan 01; 8(1):266-277.
Score: 0.151
-
Weissenbacher A, Cendales L, Morelon E, Petruzzo P, Brandacher G, Friend PJ, Gorantla V, Kaufman C, Krapf J, Levin LS, Vrakas G, Schneeberger S. Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation. Transplantation. 2018 08; 102(8):1250-1252.
Score: 0.138
-
Zamora R, Ravuri SK, Plock JA, Vodovotz Y, Gorantla VS. Differential inflammatory networks distinguish responses to bone marrow-derived versus adipose-derived mesenchymal stem cell therapies in vascularized composite allotransplantation. J Trauma Acute Care Surg. 2017 07; 83(1 Suppl 1):S50-S58.
Score: 0.128
-
Unadkat JV, Schnider JT, Feturi FG, Tsuji W, Bliley JM, Venkataramanan R, Solari MG, Marra KG, Gorantla VS, Spiess AM. Single Implantable FK506 Disk Prevents Rejection in Vascularized Composite Allotransplantation. Plast Reconstr Surg. 2017 Feb; 139(2):403e-414e.
Score: 0.125
-
Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. Transplantation. 2015 Sep; 99(9):1765-73.
Score: 0.113
-
Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, Metes DM, Donnenberg AD, Shores JT, Dimartini AF, Kiss JE, Imbriglia JE, Azari K, Goitz RJ, Manders EK, Nguyen VT, Cooney DS, Wachtman GS, Keith JD, Fletcher DR, Macedo C, Planinsic R, Losee JE, Shapiro R, Starzl TE, Lee WP. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg. 2013 Feb; 257(2):345-51.
Score: 0.095
-
Gorantla VS, Brandacher G, Schneeberger S, Zheng XX, Donnenberg AD, Losee JE, Lee WP. Favoring the risk-benefit balance for upper extremity transplantation--the Pittsburgh Protocol. Hand Clin. 2011 Nov; 27(4):511-20, ix-x.
Score: 0.087
-
Lovasik D, Foust DE, Losee JE, Lee WP, Brandacher G, Gorantla VS. Helping hands: caring for the upper extremity transplant patient. Crit Care Nurs Clin North Am. 2011 Sep; 23(3):505-17.
Score: 0.086
-
Hautz T, Brandacher G, Zelger B, Gorantla VS, Lee AW, Pratschke J, Schneeberger S. Immunologic aspects and rejection in solid organ versus reconstructive transplantation. Transplant Proc. 2010 Nov; 42(9):3347-53.
Score: 0.081
-
Gorantla VS, Schneeberger S, Brandacher G, Sucher R, Zhang D, Lee WP, Zheng XX. T regulatory cells and transplantation tolerance. Transplant Rev (Orlando). 2010 Jul; 24(3):147-59.
Score: 0.079
-
Perez-Abadia G, Laurentin-Perez L, Gorantla VS, Francois CG, Vossen M, Brouha PC, Orhun HI, Anderson GL, Maldonado C, Pidwell DJ, Breidenbach WC, Barker JH. Low-dose immunosuppression in a rat hind-limb transplantation model. Transpl Int. 2003 Dec; 16(12):835-42.
Score: 0.049
-
Elgendy TY, Waldner M, Zhang W, Kim DY, Minervini MI, Komatsu C, Kulahci Y, Washington KM, Gorantla VS, Ezzelarab MB, Solari MG, Thomson AW. Tacrolimus before CTLA4Ig and rapamycin promotes vascularized composite allograft survival in MGH miniature swine. Transpl Immunol. 2022 Dec; 75:101696.
Score: 0.046
-
Feturi FG, Unadkat JV, Zhang W, Hag ME, Wang Y, Komatsu C, Grybowski D, Zhang Z, Erbas V, Sahin H, Mcclaine S, Oksuz S, Plock J, Gorantla VS, Washington KM, Solari MG, Venkataramanan R, Spiess AM. Tacrolimus-Eluting Disk within the Allograft Enables Vascularized Composite Allograft Survival with Site-Specific Immunosuppression without Systemic Toxicity. Pharm Res. 2022 Sep; 39(9):2179-2190.
Score: 0.046
-
Fisher JD, Balmert SC, Zhang W, Schweizer R, Schnider JT, Komatsu C, Dong L, Erbas VE, Unadkat JV, Aral AM, Acharya AP, Kulahci Y, Turnquist HR, Thomson AW, Solari MG, Gorantla VS, Little SR. Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation. Proc Natl Acad Sci U S A. 2019 12 17; 116(51):25784-25789.
Score: 0.038
-
Fries CA, Lawson SD, Wang LC, Slaughter KV, Vemula PK, Dhayani A, Joshi N, Karp JM, Rickard RF, Gorantla VS, Davis MR. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study. PLoS One. 2019; 14(1):e0210914.
Score: 0.036
-
Schneeberger S, Gorantla VS, Hautz T, Pulikkottil B, Margreiter R, Lee WP. Immunosuppression and rejection in human hand transplantation. Transplant Proc. 2009 Mar; 41(2):472-5.
Score: 0.018
-
Kvernmo HD, Gorantla VS, Gonzalez RN, Breidenbach WC. Hand transplantation. A future clinical option? Acta Orthop. 2005 Feb; 76(1):14-27.
Score: 0.014
-
Prabhune KA, Gorantla VS, Perez-Abadia G, Francois CG, Vossen M, Laurentin-Perez LA, Breidenbach WC, Wang GG, Anderson GL, Pidwell DJ, Barker JH, Maldonado C. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model. Transplantation. 2003 Dec 15; 76(11):1548-55.
Score: 0.013
-
Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, Ildstad ST. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery. 2000; 20(8):441-7.
Score: 0.010